Merck plans to launch US subcutaneous version of Keytruda on October 1
Merck & Co said on Thursday that it plans to launch a subcutaneously injected version of its blockbuster cancer immunotherapy ...
Anti-Neoplastic Agents Market Report 2025: Revenues to Cross $200 Billion by 2029 due to Rising Investments in Cancer Research
Neoplastic Agents Market Report 2025" has been added to ResearchAndMarkets.com's offering.This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, ...
Le Lézard11h
ERS Genomics and Jumpcode Genomics sign CRISPR/Cas9 license agreement
ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Jumpcode Genomics ('Jumpcode'), a life science tools company improving and reducing the cost of next-generation sequencing technology, ...
Domain11h
443 Properties for sale in Adelaide, SA, 5000
Best Offers Close Thursday March 27 U.S.P.